|
MechanismRPS20 inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
Mechanism23S rRNA inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Pedanius Therapeutics Ltd.
0 Patents (Medical) associated with Pedanius Therapeutics Ltd.
100 Deals associated with Pedanius Therapeutics Ltd.
100 Translational Medicine associated with Pedanius Therapeutics Ltd.